RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 148 filers reported holding RELAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,568 | -39.1% | 8,272 | -9.0% | 0.04% | -38.2% |
| Q2 2023 | $114,196 | +19.8% | 9,092 | +57.1% | 0.07% | +30.8% |
| Q1 2023 | $95,295 | -20.3% | 5,786 | -27.7% | 0.05% | -16.1% |
| Q4 2022 | $119,580 | -28.8% | 8,004 | +6.4% | 0.06% | -7.5% |
| Q3 2022 | $168,000 | +34.4% | 7,526 | +0.7% | 0.07% | +45.7% |
| Q2 2022 | $125,000 | -24.7% | 7,476 | +34.5% | 0.05% | -37.8% |
| Q1 2022 | $166,000 | -8.3% | 5,558 | -5.6% | 0.07% | +8.8% |
| Q4 2021 | $181,000 | -7.7% | 5,885 | -5.3% | 0.07% | -20.9% |
| Q3 2021 | $196,000 | -18.0% | 6,213 | -5.1% | 0.09% | -12.2% |
| Q2 2021 | $239,000 | +0.8% | 6,544 | -4.5% | 0.10% | -2.0% |
| Q1 2021 | $237,000 | -15.4% | 6,849 | +1.7% | 0.10% | -13.8% |
| Q4 2020 | $280,000 | – | 6,732 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |